The use of lipopolysaccharide (LPS) in the LM8 cell line to activate TLR-4 resulted in the discovery of more CD8+ T cells in the tumor metastases and the suppression of tumor volume in the primary foci. This evidence concerns the gene CD8A and neoplasm.